Epidemiological Assessment of Carcinoma Types and Socio-Demographic Variables of Patients in Bangladesh
Abstract
The present investigation was a cross-sectional descriptive study conducted to assess post-natal complications and their relationships with age group, residence, family income, and other socio-demographic characteristics among patients with carcinoma. A purposive sample of 280 respondents was selected. Most participants (about 80%) were between 25 and 50 years old, and 83.6% lived with their families. In terms of monthly income, 67.5% reported earning up to 15,000 BDT. The majority were married (67.14%), and males constituted 62% of the sample. Regarding religion, 90.36% were Muslims, followed by Hindus (4.29%) and Christians (5.36%). A large proportion (74.29%) resided in rural areas. Educationally, 55.36% had completed schooling from Class VI to XII. Employment status showed that 38.93% were engaged in some form of work, while 72.50% lived in joint families. Most respondents (61.1%) reported no family history of carcinoma. Disease-related data indicated that 38.18% were in the intermediate stage (Stage II or III), and 20.21% had been living with carcinoma for five years. Lifestyle factors showed that 77.77% had no history of tobacco use, and 87.11% did not consume alcohol. A notable association was found between education and carcinoma site: 13.19% of those educated up to Class VI–XII had colon cancer, and 27.77% were in the intermediate stage. Among participants over 50 years, 27.78% had colon cancer, while 38.18% of those aged 25–50 years were in the intermediate stage. Additionally, 61.1% of respondents without a family history suffered from oral cancer, whereas only 11.11% with such a history had prostate cancer. The relationship between family history and carcinoma site was statistically significant.
Keywords: Carcinoma, Breast carcinoma, Socio-demographic factors, Cancer in Bangladesh, Tobacco use, Treatment
Keywords:
Carcinoma, Breast carcinoma, Socio-demographic factors, Cancer in Bangladesh, Tobacco use, TreatmentDOI
https://doi.org/10.22270/jddt.v15i12.7479References
1. Watson M, Wichmann M, Ganguly T. Cutaneous basal cell carcinoma requiring limb amputation. ANZ J Surg. 2019;89(12). https://doi.org/10.1111/ans.14971
2. Wadhera A, Fazio M, Bricca G, Stanton O. Metastatic basal cell carcinoma: a case report and literature review. Dermatol Online J. 2006;12(5). https://doi.org/10.5070/D313V4J8VJ
3. Lo JS, Snow SN, Reizner GT, Mohs FE, Larson PO, Hruza GJ. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol. 1991;24(5):715-9. https://doi.org/10.1016/0190-9622(91)70108-E PMid:1869642
4. Domarus HV, Stevens PJ. Metastatic basal cell carcinoma: report of five cases and review of 170 cases. J Am Acad Dermatol. 1984;10(6):1043-60. https://doi.org/10.1016/S0190-9622(84)80334-5 PMid:6736323
5. Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland, 1956-1995. Arch Dermatol. 1999;135(7):781-6. https://doi.org/10.1001/archderm.135.7.781 PMid:10411152
6. Lewis KG, Weinstock MA. Trends in nonmelanoma skin cancer mortality in the United States, 1969-2000. J Invest Dermatol. 2007;127(10):2323-7. https://doi.org/10.1038/sj.jid.5700897 PMid:17522705
7. Jensen AØ, Bautz A, Olesen AB, Karagas MR, Sørensen HT, Friis S. Mortality in Danish patients with nonmelanoma skin cancer, 1978-2001. Br J Dermatol. 2008;159(2):419-25.
8. Flohil S. Basal cell carcinoma in the Netherlands. Rotterdam: Erasmus University Rotterdam; 2012.
9. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA. Increase in incidence of basal and squamous cell skin cancer in New Hampshire. Int J Cancer. 1999;81(4):555-9. https://doi.org/10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R
10. Krause N. Church-based social support and health in old age. J Gerontol B Psychol Sci Soc Sci. 2002;57(6):S332-7. https://doi.org/10.1093/geronb/57.6.S332 PMid:12426442
11. Tarakeshwar N, Hansen N, Kochman A, Sikkema KJ. Gender, ethnicity and spiritual coping among bereaved HIV-positive individuals. Ment Health Relig Cult. 2005;8(2):109-25. https://doi.org/10.1080/1367467042000240383
12. Taylor EJ. Factors associated with meaning in life among people with recurrent cancer. Oncol Nurs Forum. 1993;20(9):1399-405.
13. Thomas J, Retsas A. Spiritual dimensions of people with terminal cancer: a grounded theory. Int J Nurs Stud. 1999;36(3):191-201. https://doi.org/10.1016/S0020-7489(99)00012-7 PMid:10404288
14. Daaleman TP, VandeCreek L. Placing religion and spirituality in end-of-life care. JAMA. 2000;284(19):2514-7. https://doi.org/10.1001/jama.284.19.2514 PMid:11074785
15. Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, et al. High breast cancer incidence among California teachers. Cancer Causes Control. 2002;13(7):625-35. https://doi.org/10.1023/A:1019552126105 PMid:12296510
16. Greer S, Morris T, Pettingale KW. Psychological response to breast cancer: effect on outcome. Lancet. 1979;314(8146):785-7. https://doi.org/10.1016/S0140-6736(79)92127-5 PMid:90871
17. Levine EG, Raczynski JM, Carpenter JT. Psychological factors, weight gain and recurrence of breast cancer: follow-up findings. In: Second International Congress of Behavioral Medicine; July 1992.
18. Levy SM. Behavior and Cancer. San Francisco: Jossey-Bass; 1985.
19. Levy SM, Lee J, Bagley C, Lippman M. Survival hazards in first recurrent breast cancer: seven-year follow-up. Biopsychosoc Med. 1988;50(5):520-8. https://doi.org/10.1097/00006842-198809000-00008 PMid:3186895
20. Glanz K, Lerman C. Psychosocial impact of breast cancer: a critical review. Ann Behav Med. 1992;14(3):204-12. https://doi.org/10.1093/abm/14.3.204
21. Irvine D, Brown B, Crooks D, Roberts J, Browne G. Psychosocial adjustment in women with breast cancer. Cancer. 1991;67(4):1097-107. https://doi.org/10.1002/1097-0142(19910215)67:4<1097::AID-CNCR2820670438>3.0.CO;2-Z PMid:1991258
22. Fleming GF, Ronnett BM, Seidman J, Zaino RJ, Rubin SC. Epithelial ovarian cancer. In: Principles and Practice of Gynecologic Oncology. 2009. p. 763-836.
23. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol. 1990; 8:253-78. https://doi.org/10.1146/annurev.iy.08.040190.001345 PMid:2188664
24. Watson JM, Sensintaffar JL, Berek JS, Martínez-Maza O. Constitutive interleukin-6 production by ovarian cancer cells. Cancer Res. 1990;50(21):6959-65.
25. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc. 1993;41(2):176-81. https://doi.org/10.1111/j.1532-5415.1993.tb02054.x PMid:8426042
26. Karimkhani C, Boyers LN, Dellavalle RP, Weinstock MA. Time to replace "nonmelanoma skin cancer" with "keratinocyte carcinoma." J Am Acad Dermatol. 2015;72(1):186-7. https://doi.org/10.1016/j.jaad.2014.09.036 PMid:25497921
27. Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong SY, Lubaroff DM. Stress, mood, and elevated IL-6 in older women. J Gerontol A Biol Sci Med Sci. 1999;54(9):M434-9. https://doi.org/10.1093/gerona/54.9.M434 PMid:10536645 PMCid:PMC6642656
28. Ilnyckyj A, Farber J, Cheang M, Weinerman BH. Psychotherapeutic intervention in cancer patients: a randomized trial. Ann R Coll Physicians Surg Can. 1994;27(2):93-6.
29. Epstein AM. Health care in America-still too separate, not yet equal. N Engl J Med. 2004;351(6):603-5. https://doi.org/10.1056/NEJMe048181 PMid:15295055
30. Weisman AD, Worden JW. Coping and vulnerability in cancer patients. Project Omega. Harvard Medical School; 1977.
31. Zhou D, Kusnecov AW, Shurin MR, DePaoli ME, Rabin BS. Stressors elevate plasma interleukin-6. Endocrinology. 1993;133(6):2523-30. https://doi.org/10.1210/endo.133.6.8243274 PMid:8243274
32. Lutgendorf SK, Anderson B, Sorosky JI, Buller RE, Lubaroff DM. Interleukin-6 and social support in gynecologic cancer. Int J Behav Med. 2000;7(2):127-42. https://doi.org/10.1207/S15327558IJBM0702_3
33. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and IL-6 increase with age. Proc Natl Acad Sci USA. 2003;100(15):9090-5. https://doi.org/10.1073/pnas.1531903100 PMid:12840146 PMCid:PMC166443
34. Maes M, Lin AH, Delmeire L, Van Gastel A, Kenis G, De Jongh R, et al. Elevated IL-6 and IL-6 receptor in PTSD. Biol Psychiatry. 1999;45(7):833-9. https://doi.org/10.1016/S0006-3223(98)00131-0 PMid:10202570
35. Dentino AN, Pieper CF, Rao KMK, Currie MS, Harris T, Blazer DG, et al. IL-6 and depression in older adults. J Am Geriatr Soc. 1999;47(1):6-11. https://doi.org/10.1111/j.1532-5415.1999.tb01894.x PMid:9920223
36. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, et al. IL-6 and disability development in old age. J Am Geriatr Soc. 1999;47(6):639-46. https://doi.org/10.1111/j.1532-5415.1999.tb01583.x PMid:10366160
37. Cohen HJ, Pieper CF, Harris T, Rao KMK, Currie MS. IL-6 and functional disability in the elderly. J Gerontol A Biol Sci Med Sci. 1997;52(4):M201-8. https://doi.org/10.1093/gerona/52A.4.M201 PMid:9224431
38. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. IL-6, CRP and physical performance in aging. J Gerontol A Biol Sci Med Sci. 2000;55(12):M709-15. https://doi.org/10.1093/gerona/55.12.M709 PMid:11129392
39. Ershler WB, Keller ET. IL-6, aging, disease, and frailty. Annu Rev Med. 2000; 51:245-70. https://doi.org/10.1146/annurev.med.51.1.245 PMid:10774463
40. Holloszy JO, Cannon JG. Cytokines in aging and muscle homeostasis. J Gerontol A Biol Sci Med Sci. 1995;50(Spec Iss):120-3. https://doi.org/10.1093/gerona/50A.Special_Issue.120 PMid:7493204
41. Burger RA, Grosen EA, Ioli GR, Van Eden ME, Park M, Berman ML, et al. IL-6 release by ovarian carcinoma cell populations. J Interferon Cytokine Res. 1995;15(3):255-60. https://doi.org/10.1089/jir.1995.15.255 PMid:7584672
42. Plante M, Rubin SC, Wong GY, Federici MG, Finstad CL, Gastl GA. Serum and ascites IL-6 as a prognostic factor in ovarian cancer. Cancer. 1994;73(7):1882-8. https://doi.org/10.1002/1097-0142(19940401)73:7<1882::AID-CNCR2820730718>3.0.CO;2-R PMid:8137215
43. Holland JC, Korzun AH, Tross S, Cella DF, Norton L, Wood W. Psychosocial factors and disease-free survival in stage II breast cancer. Proc Am Soc Clin Oncol. 1986; 5:237.
44. Jamison RN, Burish TG, Wallston KA. Psychogenic factors predicting breast cancer survival. J Clin Oncol. 1987;5(5):768-72. https://doi.org/10.1200/JCO.1987.5.5.768 PMid:3572466
45. Buddeberg C, Wolf C, Sieber M, Riehl-Emde A, Bergant A, Steiner R, et al. Coping strategies and course of breast cancer: 3-year study. Psychother Psychosom. 1991;55(2-4):151-7. https://doi.org/10.1159/000288423 PMid:1891562
Published
Abstract Display: 106 
PDF Downloads: 69 PDF Downloads: 17 How to Cite
Issue
Section
Copyright (c) 2025 Mahfuz Kabir , Mujtaba Rafid Hasan , Md. Kamrul Hassan , Sirajum Munira , Bishoonath Paul , Ezaj Ahmed Mehadi, Hosne Ara, Hafizur Rahman , Sumon Karmakar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.